NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Avalon GloboCare Corp (NASDAQ: AVCO)
AVCO Technical Analysis
5
As on 14th Dec 2022 AVCO STOCK Price closed @ 0.43 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.84 & Strong Sell for SHORT-TERM with Stoploss of 0.97 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AVCOSTOCK Price
Open | 0.40 | Change | Price | % |
High | 0.46 | 1 Day | 0.04 | 10.26 |
Low | 0.40 | 1 Week | 0.06 | 16.22 |
Close | 0.43 | 1 Month | 0.01 | 2.38 |
Volume | 267649 | 1 Year | -0.58 | -57.43 |
52 Week High 1.16 | 52 Week Low 0.00 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
AVCO Daily Charts |
AVCO Intraday Charts |
Whats New @ Bazaartrend |
AVCO Free Analysis |
|
AVCO Important Levels Intraday
RESISTANCE | 0.55 |
RESISTANCE | 0.51 |
RESISTANCE | 0.49 |
RESISTANCE | 0.46 |
SUPPORT | 0.40 |
SUPPORT | 0.37 |
SUPPORT | 0.35 |
SUPPORT | 0.31 |
AVCO Forecast May 2024
4th UP Forecast | 1.18 |
3rd UP Forecast | 0.94 |
2nd UP Forecast | 0.79 |
1st UP Forecast | 0.64 |
1st DOWN Forecast | 0.22 |
2nd DOWN Forecast | 0.07 |
3rd DOWN Forecast | -0.08 |
4th DOWN Forecast | -0.32 |
AVCO Weekly Forecast
4th UP Forecast | 0.70 |
3rd UP Forecast | 0.61 |
2nd UP Forecast | 0.56 |
1st UP Forecast | 0.51 |
1st DOWN Forecast | 0.35 |
2nd DOWN Forecast | 0.30 |
3rd DOWN Forecast | 0.25 |
4th DOWN Forecast | 0.16 |
AVCO Forecast2024
4th UP Forecast | 2.72 |
3rd UP Forecast | 1.99 |
2nd UP Forecast | 1.53 |
1st UP Forecast | 1.08 |
1st DOWN Forecast | -0.22 |
2nd DOWN Forecast | -0.67 |
3rd DOWN Forecast | -1.13 |
4th DOWN Forecast | -1.86 |
Avalon GloboCare Corp ( NASDAQ USA Symbol : AVCO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AVCO Other Details
Segment | EQ | |
Market Capital | 86259960.00 | |
Sector | Healthcare | |
Industry | Medical Care Facilities | |
Offical website | > echo $website ; ?> |
AVCO Address
AVCO Latest News
AVCO Business Profile
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. It also develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology. In addition, the company develops proprietary diagnostic and therapeutic products leveraging exosome technology; and provides development services for hospitals. The company has a strategic partnership with Weill Cornell Medical College to co-develop bio-production and standardization procedures for chimeric antigen receptor (CAR)-T Therapy; GensKey Medical Technology Co. Ltd. to co-develop and commercialize point-of-care, rapid detection antibody tests to identify whether a patient has been exposed to and has developed antibodies against SARS-CoV-2; GE Healthcare to enhance standardized automation and bio-production for cellular medicines; and HydroPeptide, LLC to co-develop and commercialize various clinical-grade, exosome-based cosmeceutical and orthopedic products, as well as research agreement with Massachusetts Institute of Technology to develop CAR technology; and with University of Pittsburgh of the Commonwealth System of Higher Education. It also has a collaboration agreement with the UPMC Hillman Cancer Center to advance the clinical development and production of CAR therapies using FLASH CAR technology. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey. Address: 4400 Route 9 South, Freehold, NJ, United States, 07728
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service